Status:
COMPLETED
Trial Comparing Prone and Supine Intensity-modulated Radiotherapy (IMRT) After Breast-conserving Surgery in Patients With Large Breast Volume at High Risk for Skin Toxicity and Fibrosis
Lead Sponsor:
University Hospital, Ghent
Collaborating Sponsors:
National Cancer Plan, France
Conditions:
Breast Carcinoma
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
84 patients with a cup size C or more will be randomized to receive intensity-modulated radiotherapy in supine or prone position.
Eligibility Criteria
Inclusion
- female patients
- multidisciplinary decision of adjuvant whole-breast irradiation (WBI) after lumpectomy for breast cancer
- minimum 18 years
- informed consent obtained, signed and dated before specific protocol procedures
Exclusion
- mastectomy
- need for axillary irradiation
- bilateral breast irradiation
- previous irradiation at the same time
- mental condition rendering the patient unable to understand the nature, scope and possible consequences of the study
- patient unlikely to comply with the protocol; i.e. uncooperative attitude, inability to return for follow-up visits, and unlikely to complete the study.
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 8 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00887523
Start Date
July 1 2009
End Date
March 8 2021
Last Update
December 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Ghent
Ghent, Belgium, 9000